Systemic Psoriasiform Dermatitis Appeared after the Administration of Pembrolizumab

Intern Med. 2020 Mar 15;59(6):871-872. doi: 10.2169/internalmedicine.3694-19. Epub 2019 Nov 29.

¹ Department of Respiratory Medicine, National Center for Global Health and Medicine, Japan.

No abstract available

Keywords: PD-L1; immune checkpoint inhibitors; immune-related adverse event (irAE); psoriasiform dermatitis; psoriasis-like rashes.